PRSCX Performance — T. Rowe Price Science & Technology Fund, Inc.
Data updated: 2026-08-27
PRSCX returned +41.74% year to date and +68.66% over one year to Jun 2026. Annualised returns are +39.41% over 3 years and +17.55% over 5 years. The fund beat its Technology Equity category average: $100 invested three years ago grew to $271, against $225 for the category, and to $169 over one year, against $146. Volatility over the past three years was 25.45% a year. In the 12 months to Jun 2026 the fund took in a net $651.0M, and assets reached $16.47B.
PRSCX Growth of $100
What $100 invested in T. Rowe Price Science & Technology Fund, Inc. grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Technology Equity category average over the same months.
| Period | PRSCX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $169 | $146 |
| 3 years (Jul 2023 – Jun 2026) | $271 | $225 |
| 5 years (Jul 2021 – Jun 2026) | $224 | $201 |
| Since data start (Jul 2019 – Jun 2026) | $439 | $379 |
PRSCX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +41.74% |
| 1 year | +68.66% |
| 3 years (annualised) | +39.41% |
| 5 years (annualised) | +17.55% |
PRSCX Annual Returns
Calendar-year total returns of T. Rowe Price Science & Technology Fund, Inc., compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +41.74% |
| 2025 | +24.43% |
| 2024 | +40.27% |
| 2023 | +53.77% |
| 2022 | −35.20% |
| 2021 | +5.50% |
| 2020 | +45.80% |
| 2019 (Jul–Dec) | +15.74% |
PRSCX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +5.0% | −2.1% | −9.8% | +23.6% | +18.6% | +4.2% | — | — | — | — | — | — |
| 2025 | +1.0% | −6.8% | −10.4% | +0.7% | +9.5% | +12.4% | +5.2% | +0.5% | +8.6% | +8.4% | −2.8% | −1.7% |
| 2024 | +4.0% | +9.9% | +2.4% | −5.8% | +7.8% | +6.6% | −3.7% | +2.1% | +3.2% | 0.0% | +7.4% | +1.7% |
| 2023 | +16.7% | −2.3% | +11.3% | −0.9% | +6.8% | +4.7% | +6.2% | −2.7% | −6.2% | −2.8% | +12.3% | +3.6% |
| 2022 | −6.4% | −8.3% | −2.0% | −13.4% | −1.6% | −4.3% | +9.3% | −5.5% | −11.3% | −0.5% | +12.2% | −7.6% |
| 2021 | +1.4% | +5.2% | +0.9% | +4.4% | −1.1% | +4.2% | −4.8% | +3.2% | −4.8% | +3.0% | −2.6% | −3.0% |
| 2020 | +0.9% | −4.3% | −13.0% | +13.8% | +9.1% | +5.3% | +6.1% | +9.0% | −3.1% | −0.2% | +12.2% | +5.8% |
| 2019 | — | — | — | — | — | — | +3.4% | −1.1% | 0.0% | +4.8% | +3.0% | +4.8% |
PRSCX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 25.45%
- 3-year Sharpe ratio: 1.37 (vs 4.5% risk-free rate)
- Best month: +23.59% (Apr 2026)
- Worst month: −10.39% (Mar 2025)
PRSCX Fund Flows
Monthly money in and out of T. Rowe Price Science & Technology Fund, Inc., from SEC Form N-PORT.
- 12-month net flow: $651.0M
- 12-month gross sales (incl. reinvestments): $3.4B
- Sales ÷ redemptions: 1.24×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $391.6M | $410.2M | −$18.6M |
| May 2026 | $312.0M | $203.2M | $108.8M |
| Apr 2026 | $138.9M | $164.6M | −$25.7M |
| Mar 2026 | $66.7M | $183.7M | −$117.0M |
| Feb 2026 | $187.8M | $376.2M | −$188.4M |
| Jan 2026 | $139.1M | $190.3M | −$51.2M |
| Dec 2025 | $1.3B | $185.0M | $1.1B |
| Nov 2025 | $408.0M | $373.0M | $35.0M |
| Oct 2025 | $147.4M | $194.2M | −$46.8M |
| Sep 2025 | $85.8M | $126.1M | −$40.3M |
| Aug 2025 | $122.7M | $190.1M | −$67.4M |
| Jul 2025 | $88.3M | $152.4M | −$64.1M |
PRSCX Assets Under Management
Net assets of T. Rowe Price Science & Technology Fund, Inc. by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $16.47B |
| 2026-03-31 | $10.74B |
| 2025-12-31 | $11.92B |
| 2025-09-30 | $11.64B |
| 2025-06-30 | $10.29B |
| 2025-03-31 | $8.47B |
| 2024-12-31 | $10.29B |
| 2024-09-30 | $9.67B |
| 2024-06-30 | $9.75B |
| 2024-03-31 | $9.18B |
| 2023-12-31 | $7.75B |
| 2023-09-30 | $6.93B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.